For the safety of our patients and staff, we have updated our visitor policy, effective December 27. This includes important information about COVID-19 vaccination or testing for some visitors. Read the latest information for visitors.
The Division of Hematologic Malignancies within Memorial Sloan Kettering’s Department of Medicine is dedicated to treating patients with a variety of blood cancers as well as some benign hematologic diseases. Our physicians and scientists are central players in advancing translational and clinical research and establishing the standard of care for patients with hematologic cancers.